Montes Archimedes Acquisition (ROIV)
(Delayed Data from NSDQ)
$11.00 USD
-0.11 (-0.99%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $11.00 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum F VGM
Earnings News For ROIV
-
Roivant Sciences Ltd. (ROIV) Reports Q4 Loss, Misses Revenue Estimates
-
Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provides Business Update
-
Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provide Business Update on Thursday, May 30, 2024
-
Roivant Reports Financial Results for the Third Quarter Ended December 31, 2023, and Provides Business Update
-
Roivant Reports Financial Results for the Second Quarter Ended September 30, 2023, and Provides Business Update
-
Roivant Reports Financial Results for the First Quarter Ended June 30, 2023, and Provides Business Update
-
UPDATE -- Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2023, and Provides Business Update
-
Roivant Sciences Ltd. (ROIV) Reports Q4 Loss, Tops Revenue Estimates
-
Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2023, and Provides Business Update
-
Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2023, and Provide Business Update on Wednesday, June 28, 2023
-
Roivant Sciences Ltd. (ROIV) Reports Q3 Loss, Tops Revenue Estimates
-
Roivant Sciences Reports Financial Results for the Third Quarter Ended December 31, 2022 and Provides Business Update
-
Roivant Sciences Ltd. (ROIV) Reports Q2 Loss, Tops Revenue Estimates
-
Roivant Sciences Reports Financial Results for the Second Quarter Ended September 30, 2022 and Provides Business Update
-
Analysts Estimate Roivant Sciences Ltd. (ROIV) to Report a Decline in Earnings: What to Look Out for
-
Roivant Sciences Ltd. (ROIV) Reports Q1 Loss, Misses Revenue Estimates